December 13, 2019
Opiant Pharmaceuticals Announces Contract Extension of Second Tranche of Approximately $2.4 Million from Biomedical Advanced Research and Development Authority for Development of OPNT003, Nasal Nalmefene, for the Treatment of Opioid Overdose
SANTA MONICA, Calif., Dec. 12, 2019 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, ...
December 13, 2019
Beyond Air, Inc. Announces Closing of $11.5 Million Public Offering and Private Placement of Common Stock and Exercise of Option to Purchase Additional Shares
GARDEN CITY, N.Y. and REHOVOT, Israel, Dec. 12, 2019 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (XAIR), a clinical-stage medical device and biopharmaceutical company focused on ...
December 13, 2019
Valneva Appoints MVM Partner Thomas Casdagli to its Supervisory Board
Saint-Herblain (France), December 12, 2019 – Valneva SE (“Valneva” or “the Company”) today announced the appointment of MVM Partner Thomas Casdagli to its Supervisory Board. ...
December 13, 2019
General Meeting approved the project to transfer Pixium Vision’s shares listing to the Euronext Growth Paris market
Paris, 13 December 2019 – 7.00 AM CET – The Ordinary General Meeting of Pixium Vision (FR0011950641 - PIX), held today, approved the proposed transfer ...
December 13, 2019
BioLineRx Announces Updated Phase 2a Data From Triple Combination Arm of COMBAT/KEYNOTE-202 Study in Patients With Second-line Metastatic Pancreatic Cancer
TEL AVIV, Israel, Dec. 13, 2019 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology, announced today updated data from ...
December 13, 2019
Arrowhead Pharmaceuticals Appoints Marianne De Backer to Board of Directors
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that the board of directors appointed veteran pharmaceutical industry executive Marianne De Backer, Ph.D., as an independent director ...
December 13, 2019
Phio Pharmaceuticals Announces Adjournment of Special Meeting of Stockholders
MARLBOROUGH, Mass., Dec. 13, 2019 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its ...
December 13, 2019
Marinus Pharmaceuticals Announces Closing of $70 Million Public Offering of Common Stock and Concurrent Private Placement Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
RADNOR, Pa., Dec. 13, 2019 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS), (“Marinus” or the “Company”) today announced the closing of an underwritten public ...
December 13, 2019
Intercept Provides Regulatory Update
NEW YORK, Dec. 13, 2019 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to ...
December 13, 2019
Athenex Announces Superior Response and Survival with Lower Neuropathy of a Novel Oral Paclitaxel versus IV Paclitaxel in Treatment of Metastatic Breast Cancer
BUFFALO, N.Y., Dec. 13, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. (ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies ...
December 13, 2019
Cellectar Presents Poster at the American Association for Cancer Research (AACR) San Antonio Breast Cancer Symposium
FLORHAM PARK, N.J., Dec. 13, 2019 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs ...
December 13, 2019
Patent Detecting How Patients Respond to Folate-based Cancer Treatment Approved in the USA
GOTHENBURG, Sweden, Dec. 13, 2019 /PRNewswire/ -- Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), today announces the approval from the United States Patent ...
December 12, 2019
CytoDyn to Hold Investment Community Conference Call on December 17, 2019
VANCOUVER, Washington, Dec. 11, 2019 (GLOBE NEWSWIRE) -- CytoDyn Inc. (CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 ...
December 12, 2019
Pixium Vision reaches finalist status in 18th Paris Innovation Grand Prix award
With its Prima system, Pixium Vision is bringing breakthrough technologies to people suffering from dry Age-related Macular Degeneration Paris, France, December 12, 2019 – 08:00 ...
December 12, 2019
Oncolytics Biotech(R) Announces Abstract Outlining Potential New Biomarker to be Presented at the 2020 Gastrointestinal Cancers Symposium
SAN DIEGO, CA and CALGARY, AB / ACCESSWIRE / December 12, 2019 / Oncolytics Biotech® Inc. (ONCY)(ONC.TO), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, ...
December 12, 2019
Trevena Presents Phase 1 Data on TRV250 for Acute Migraine at American College of Neuropsychopharmacology 2019 Annual Meeting
Safety, tolerability, and PK profile support potential utility as a novel acute migraine treatment option CHESTERBROOK, Pa., Dec. 12, 2019 (GLOBE NEWSWIRE) -- Trevena, Inc. ...
December 12, 2019
Equillium & Biocon Expand Exclusive Licensing Agreement for Itolizumab to Include Australia and New Zealand
LA JOLLA, Calif. and BENGALURU, India, Dec. 12, 2019 (GLOBE NEWSWIRE) -- Equillium Inc. (EQ), a clinical-stage biotechnology company leveraging deep understanding of immunobiology to ...
December 12, 2019
Marinus Pharmaceuticals Appoints Elan Ezickson to Board of Directors
RADNOR, Pa., Dec. 12, 2019 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (MRNS) (“Marinus” or “Company”), a pharmaceutical company dedicated to the development of innovative therapeutics ...
December 12, 2019
aTyr Pharma Announces Positive Interim Safety Results from Ongoing Phase 1b/2a Clinical Trial of ATYR1923
ATYR1923 safe and well tolerated in initial 15 randomized patients with pulmonary sarcoidosis No drug-related serious adverse events observed SAN DIEGO, Dec. 12, 2019 (GLOBE ...
December 12, 2019
Salarius Pharmaceuticals to Present Trial-in-Progress Poster at Epigenetics Symposium: 15 Years of Lysine Demethylases: From Discovery to the Clinic
Presentation Will Provide Overview of Ongoing Clinical Trial of Salarius’ Lead Drug Candidate, Seclidemstat, in Ewing Sarcoma HOUSTON, Dec. 12, 2019 (GLOBE NEWSWIRE) -- Salarius ...
Page 135 of 178